Select Publications
Journal articles
2016, 'A survey of Sydney general practitioners' management of patients with chronic hepatitis B', The Medical journal of Australia, 204, http://dx.doi.org/10.5694/mja15.00524
,2016, 'Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: Position paper produced by Australian, UK and New Zealand key opinion leaders', Gut, 65, pp. 340 - 350, http://dx.doi.org/10.1136/gutjnl-2015-310317
,2015, 'Corrigendum to "efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus" (J Hepatol (2014) 61:502-507)', Journal of Hepatology, 63, pp. 1054, http://dx.doi.org/10.1016/j.jhep.2015.07.017
,2015, 'Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis', Journal of Gastroenterology and Hepatology (Australia), 30, pp. 453 - 462, http://dx.doi.org/10.1111/jgh.12865
,2014, 'A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection', AIDS Research and Therapy, 11, http://dx.doi.org/10.1186/1742-6405-11-35
,2014, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', Journal of Viral Hepatitis, 21, pp. 809 - 817, http://dx.doi.org/10.1111/jvh.12212
,2014, 'Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum flare', Alimentary Pharmacology and Therapeutics, 39, pp. 1225 - 1234, http://dx.doi.org/10.1111/apt.12726
,2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424
,2014, 'Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus', Journal of Hepatology, 61, pp. 502 - 507, http://dx.doi.org/10.1016/j.jhep.2014.04.038
,2014, 'Editorial: anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post-partum flare; authors' reply', Alimentary Pharmacology & Therapeutics, 40, pp. 116 - 116, http://dx.doi.org/10.1111/apt.12806
,2012, 'Lamivudine in pregnancy: impact on hepatitis flares and HBeAg seroconversion post partum', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27, pp. 181 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600367&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'The hepatitis B bear: novel patient orientated information enhances patient understanding of the phases of hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27, pp. 166 - 166, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'Preventing Perinatal Transmission of HBV: An Australian Perspective', Current Hepatitis Reports, 11, pp. 206 - 212, http://dx.doi.org/10.1007/s11901-012-0144-4
,2011, 'Nucleot(s)ide analogues to prevent perinatal transmission of HBV: Lamivudine is effective but Tenofovir may be better', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, pp. 100 - 100, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'ANTIVIRAL-THERAPY IN PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: SEVERE POST PARTUM HEPATIC FLARES ARE COMMON AND USUALLY SELF LIMITING', JOURNAL OF HEPATOLOGY, 54, pp. S294 - S295, http://dx.doi.org/10.1016/S0168-8278(11)60735-6
,2010, 'Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: Effects on health services utilisation', BMC Health Services Research, 10, http://dx.doi.org/10.1186/1472-6963-10-215
,2010, 'Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia', Journal of Hepatology, 52, pp. 508 - 513, http://dx.doi.org/10.1016/j.jhep.2010.01.007
,2010, 'Liver transient elastography (Fibroscan®): A place in the management algorithms of chronic viral hepatitis', Antiviral Therapy, 15, pp. 1 - 11, http://dx.doi.org/10.3851/IMP1474
,2010, 'Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand', Transplantation, 90, pp. 1165 - 1171, http://dx.doi.org/10.1097/TP.0b013e3181f92548
,2009, 'Serum HBeAg and HBsAg titres: changing levels during the natural history of chronic hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A299 - A299, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'In reply', Medical Journal of Australia, 191, pp. 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x
,2009, 'Perinatal transmission of hepatitis B virus: an Australian experience REPLY', MEDICAL JOURNAL OF AUSTRALIA, 191, pp. 357 - 357, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02829.x
,2009, 'Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer', Journal of Hepatology, 50, pp. 990 - 998, http://dx.doi.org/10.1016/j.jhep.2008.12.022
,2009, 'Perinatal transmission of hepatitis B virus: an Australian experience', Medical Journal of Australia, 190, pp. 489 - 492
,2009, 'Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users', Health Promotion Journal of Australia, 20, pp. 234 - 240
,2008, 'Hepatitis C has a significant impact after renal transplantation: analysis of the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, pp. A260 - A260, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most', Internal Medicine Journal, 37, pp. 516 - 522
,2002, 'Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate', Journal of Hepatology, 37, pp. 214 - 221, http://dx.doi.org/10.1016/S0168-8278(02)00103-4
,2000, 'Molecular pathogenesis of liver disease: An approach to hepatic inflammation, cirrhosis and liver transplant tolerance', Immunological Reviews, 174, pp. 172 - 191, http://dx.doi.org/10.1034/j.1600-0528.2002.017420.x
,2000, 'Oncostatin M: A cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells', Journal of Hepatology, 32, pp. 218 - 226, http://dx.doi.org/10.1016/S0168-8278(00)80066-5
,1999, 'Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain', European Journal of Biochemistry, 266, pp. 798 - 810, http://dx.doi.org/10.1046/j.1432-1327.1999.00902.x
,1999, 'Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis', Hepatology, 29, pp. 1768 - 1778, http://dx.doi.org/10.1002/hep.510290631
,1999, 'Posterior pharyngolaryngitis. Double-blind randomised placebo-controlled trial of proton pump inhibitor therapy', Australian Journal of Otolaryngology, 3, pp. 243 - 246
,1999, 'Posterior pharyngolaryngitis: Double-blind placebo controlled trial of proton pump inhibitor therapy', Australian Journal of Otolaryngology, pp. 243 - 246
,1997, 'Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: Referral patterns and transplant outcomes', Journal of Gastroenterology and Hepatology (Australia), 12, pp. 453 - 459, http://dx.doi.org/10.1111/j.1440-1746.1997.tb00466.x
,1997, 'Molecular analyses of human and rat dipeptidyl peptidase IV', Advances in Experimental Medicine and Biology, 421, pp. 161 - 169, http://dx.doi.org/10.1007/978-1-4757-9613-1_21
,1996, 'Case Report: Delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis', Journal of Gastroenterology and Hepatology (Australia), 11, pp. 734 - 737, http://dx.doi.org/10.1111/j.1440-1746.1996.tb00323.x
,1993, 'Viral markers in the treatment of hepatitis B and C', Gut, 34
,